Tranexamic Acid (500mg) + Mefenamic Acid (250mg)
Tranfib MF 500 mg/250 mg Tablet is a combination medication indicated for the treatment of menstrual pain and excessive menstrual hemorrhage. It functions by inhibiting the production of specific chemical mediators that induce inflammation and pain, as well as by preventing the disintegration of blood clots to regulate excessive bleeding during periods.
Tranfib MF 500 mg/250 mg Tablet is a medication that is prescribed to alleviate the symptoms of excessive menstrual bleeding and associated pain. It is a combination of Tranexamic Acid and Mefenamic Acid. The medication functions by inhibiting the formation of blood clotting and alleviating inflammation and pain associated with menstruation. For optimal efficacy, it should be administered with sustenance and on the first day of menstruation on the prescribed schedule.
Medical intervention is not necessary for the majority of adverse effects, which typically resolve as the body adapts to the medication. If you are experiencing persistent side effects or have any concerns, it is recommended that you consult with your physician.
strip of 10 tablets
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
As directed by your physician, you should consume Tranfib MF 500 mg/250 mg Tablet. Do not chew, pulverize, or split the tablet; instead, swallow it whole with food. For optimal results, it is recommended that you administer this medication at the same time each day, commencing on the first day of your menstrual cycle. Do not double the dose if it is near the time of your next dose, but take it as soon as you remember if you miss a dose.
Mefenamic Acid, a non-steroidal anti-inflammatory drug (NSAID), is combined with Tranexamic Acid, an anti-fibrinolytic, in the Tranfib MF 500 mg/250 mg Tablet. Tranexamic acid is used to regulate excessive bleeding during periods by preventing the disintegration of blood clotting. Mefenamic acid alleviates menstrual pain by inhibiting the production of prostaglandins, chemical mediators that induce inflammation and pain.
Related Warnings
It is not recommended to consume alcohol while taking Tranfib MF 500 mg/250 mg Tablet, as it may lead to an increased risk of side effects.
Tranfib MF 500 mg/250 mg Tablet may not be safe for use during pregnancy. The potential damage to the developing baby is suggested by limited investigations in humans and animal models. If you are pregnant, your physician will assess the advantages and disadvantages of this medication prior to prescribing it.
It is probable that the use of Transfib MF 500 mg/250 mg Tablet is safe during breastfeeding. The medication does not appear to pose a substantial risk to the neonate, according to the limited human data. Nevertheless, it is imperative to consult with your physician prior to administering this medication while breastfeeding.
Tranfib MF 500 mg/250 mg Tablet may induce vertigo and drowsiness, impair alertness, or affect vision. If these symptoms are present, refrain from operating a motor vehicle.
Tranfib MF 500 mg/250 mg Tablet should be used with caution by patients who have kidney disease. It is not advised for patients with severe kidney disease to use this medication, and dosage adjustments may be required.
It is probable that Tranfib MF 500 mg/250 mg Tablet is safe for patients with liver disease. Limited data indicates that dose adjustments may not be necessary; however, it is imperative to consult with your physician prior to administering this medication.
Q: What is the purpose of Tranfib MF 500 mg/250 mg Tablet?
A: Tranfib MF 500 mg/250 mg Tablet is administered to alleviate menstrual pain and excessive menstrual hemorrhage. It assists in the regulation of excessive hemorrhage and the alleviation of pain and inflammation.
Q: Is it permissible to consume alcohol while consuming Tranfib MF 500 mg/250 mg Tablet?
A: No, it is not safe to consume alcohol while taking this medication, as it may increase the risk of side effects.
Q: Prior to administering Tranfib MF 500 mg/250 mg Tablet, what information should I provide to my physician?
A: Please notify your physician of any kidney or liver disease, pregnancy, lactation, or other medical conditions. Additionally, please provide information regarding any additional medications or supplements that you are currently taking.
Q: In the event that I neglect to take a dose of Tranfib MF 500 mg/250 mg Tablet, what should I do?
A: Take the delayed dose as soon as you recall. Skip the missed dose and resume your regular dosage schedule if it is nearly time for your next dose. Do not increase the dosage to compensate for the skipped one.
Q: Is it permissible for patients with kidney disease to utilize Tranfib MF 500 mg/250 mg Tablet?
A: Patients with kidney disease should exercise caution when administering this medication. It is not advised for patients with severe kidney disease, and dosage adjustments may be necessary. Seek guidance from your physician.
